Price Performance
- Day's Low
- ₹140.5
- Day's High
- ₹144.75
₹ 141.6
- 52-w low
- ₹68.5
- 52-w high
- ₹179.3
141.6
- Day's open
₹142.75 - Previous close
₹142.550003 - VWAP
₹142.29 - Lower price band
₹114.05 - Upper price band
₹171.05
Today's Market Action
The last traded share price of Marksans Pharma Ltd was 141.60 down by -0.67% on the NSE. Its last traded stock price on BSE was 141.60 down by -0.56%. The total volume of shares on NSE and BSE combined was 507,019 shares. Its total combined turnover was Rs 7.21 crores.
Medium and Long Term Market Action
Marksans Pharma Ltd hit a 52-week high of 179.3 on 03-01-2024 and a 52-week low of 68.5 on 20-03-2023.
The stock price of Marksans Pharma Ltd is down by -12% over the last one month. It is up by 104.48% over the last one year. Don't forget to check the full stock price history in the table below.
Fundamentals
-
Market Cap (Cr): 6460
-
Book Value (₹):
-
Stock P/E:
-
Revenue (Cr):
-
Total Debt (Cr):
-
Face Value (₹):
-
Roce (%):
-
ROE (%):
-
Earnings (Cr):
-
Promoter’s Holdings (%):
-
EPS (₹):
-
Debt to Equity:
-
Dividend Yield (%):
-
Cash (Cr):
Mutual fund holdings and trends
FUND NAME | Quantity | Monthly Change (Qty) |
---|
Similar Stocks
Company | Price | Market Cap (Cr) | P/E |
---|
About
Data not available.
FAQ's
What is Share Price of Marksans Pharma Ltd?
What is the Market Cap of Marksans Pharma Ltd?
What is PE Ratio of Marksans Pharma Ltd?
What is PB Ratio of Marksans Pharma Ltd?
What is the CAGR of Marksans Pharma Ltd?
How to Buy Marksans Pharma Ltd Share?
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Net Profit)
Standalone Financial Performace In Graph(Net Profit)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Net Profit)
Standalone Financial Performace In Graph(Net Profit)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Cash Flow)
Standalone Financial Performace In Graph(Cash Flow)
Pros
Momentum Strength
Above Average Sustainable RoE
Zero Debt
High Shareholder Pedigree
Cons
Low Return on Capital Employed
Highly Cyclical Industry
Poor Capital Allocation
Poor Working Capital Cycle
Valuation Analysis
Margin of safety
(19/03/2024)
(19/03/2024)
96
100.00%
100.00% People are bullish about Marksans Pharma Ltd
0.00%
0.00 % People are bearish about Marksans Pharma Ltd